Shanghai Kaibao Pharmaceutical CO.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 794.95 million compared to CNY 647.78 million a year ago. Revenue was CNY 794.95 million compared to CNY 647.78 million a year ago. Net income was CNY 115.5 million compared to CNY 105.74 million a year ago. Basic earnings per share from continuing operations was CNY 0.1104 compared to CNY 0.1011 a year ago. Diluted earnings per share from continuing operations was CNY 0.1104 compared to CNY 0.1011 a year ago.